We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Our gynaecological oncology service is a state leader in treating women diagnosed with gynaecological cancer.
This includes treatment for endometrial, ovarian, cervical, vulval and vaginal malignancies, as well as familial cancers, complex gynaecological surgery and pre-invasive conditions.
Our specialist team includes gynaecological oncologists Professor Lew Perrin, Dr Naven Chetty, Dr Nimithri Cabraal and Dr Nisha Jagasia.
Caring for private and public patients, Mater gynaecological oncology is focused on improving treatment outcomes for women by adopting advanced minimally invasive surgery techniques, including laparascopic and robotic surgery.
The service works closely with Mater Research and the Queensland Centre for Gynaecological Cancer Research (QCGC Research). It is currently driving and participating in some 21 research projects which are underway in Australia and overseas.
Mater gynaecological oncology is also one of only a small number of services in Australia trialling Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer, a novel treatment associated with significantly improved survival. Once established it is anticipated this treatment will be introduced in gynaecological oncology units throughout Australia.